Higher cardiometabolic index (LnCMI≥-2) was associated with a 92% higher odds of depressive symptoms (OR 1.92, 95% CI 1.40-2.64) in US adults.
Cross-Sectional (n=7,965)
Yes
Is a higher cardiometabolic index associated with an increased prevalence of depressive symptoms in US adults?
A higher cardiometabolic index exhibits a J-shaped association with increased odds of depressive symptoms in US adults, with the risk particularly pronounced in overweight and obese individuals.
Effect estimate: OR 1.92 (95% CI 1.40-2.64)
p-value: p=0.003
Our research findings suggest a strong association between higher CMI levels and increased prevalence of depressive symptoms, particularly among American adults with BMI ≥ 25 kg/m2. We further revealed a turning point by threshold effect analysis.
Yu et al. (2026) conducted a cross-sectional in U.S. adults aged ≥18 years with complete data on cardiometabolic index and depressive symptoms (n=7,965). Cardiometabolic Index (CMI) vs. Lower CMI levels was evaluated on Prevalence of depressive symptoms defined as PHQ-9 score ≥10 (OR 1.92, 95% CI 1.40-2.64, p=0.003). Higher cardiometabolic index (LnCMI≥-2) was associated with a 92% higher odds of depressive symptoms (OR 1.92, 95% CI 1.40-2.64) in US adults.